OSTEOGENESIS IMPERFECTA, TYPE XVI
|
0.400 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A homozygous pathogenic missense variant broadens the phenotypic and mutational spectrum of CREB3L1-related osteogenesis imperfecta.
|
30657919 |
2019 |
OSTEOGENESIS IMPERFECTA, TYPE XVI
|
0.400 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Osteogenesis imperfecta type III (disorder)
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Deficiency for the ER-stress transducer OASIS causes severe recessive osteogenesis imperfecta in humans.
|
24079343 |
2013 |
Fibromyxosarcoma
|
0.300 |
FusionGene
|
disease |
ORPHANET |
|
|
|
Osteogenesis Imperfecta
|
0.150 |
GeneticVariation
|
disease |
BEFREE |
Deficiency of OASIS is linked to a severe form of autosomal recessive osteogenesis imperfecta (OI), but only few patients have been reported.
|
30657919 |
2019 |
Osteogenesis Imperfecta
|
0.150 |
GeneticVariation
|
disease |
BEFREE |
We report a novel homozygous CREB3L1 mutation in a large Indonesian family; the homozygous affected members have survived to adulthood and they present a more severe phenotype than previously reported, expanding the clinical spectrum of OI for this gene.
|
31207160 |
2019 |
Osteogenesis Imperfecta
|
0.150 |
Biomarker
|
disease |
BEFREE |
Here, we expand the clinical spectrum by a detailed phenotypic characterization of the first case of OASIS-associated OI surviving the neonatal period, with heterozygous family members being unaffected.
|
29936144 |
2018 |
Osteogenesis Imperfecta
|
0.150 |
GeneticVariation
|
disease |
BEFREE |
We sought the genetic cause of mild and lethal OI phenotypes in an unsolved family.MethodsWe performed exome sequencing on seven members of the family, both affected and unaffected.ResultsWe identified a variant in cyclic AMP responsive element binding protein 3-like 1 (CREB3L1) in a consanguineous family.
|
28817112 |
2018 |
Osteogenesis Imperfecta
|
0.150 |
Biomarker
|
disease |
BEFREE |
This is the first report linking CREB3L1 to human recessive OI, thereby expanding the OI gene spectrum.
|
24079343 |
2013 |
Osteogenesis Imperfecta
|
0.150 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Osteopenia
|
0.110 |
AlteredExpression
|
disease |
BEFREE |
OASIS is a transcription factor highly expressed in osteoblasts, and OASIS<sup>-/-</sup> mice exhibit severe osteopenia and spontaneous fractures.
|
29936144 |
2018 |
Osteopenia
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Osteopenia
|
0.110 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Systolic Pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Peripheral Arterial Diseases
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Genome-wide association study of peripheral artery disease in the Million Veteran Program.
|
31285632 |
2019 |
Low density lipoprotein cholesterol measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program.
|
30275531 |
2018 |
Mood Disorders
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways.
|
29942085 |
2018 |
mathematical ability
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals.
|
30038396 |
2018 |
Major Depressive Disorder
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways.
|
29942085 |
2018 |
Leukemia, Myelocytic, Acute
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia.
|
27903959 |
2017 |
Fasting blood glucose measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance.
|
22581228 |
2012 |
Conductive hearing loss
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Joint laxity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Small for gestational age (disorder)
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Compression fracture of vertebral column
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|